Order Article Reprints

Hashimoto I, Kano K, Onuma S, Suematsu H, Nagasawa S, Kanematsu K, Furusawa K, Hamaguchi T, Watanabe M, Hayashi K, et al. Clinical Effect of the C-Reactive Protein to Serum Albumin Ratio in Patients with Metastatic Gastric or Gastroesophageal Junction Cancer Treated with Trifluridine/Tipiracil. Journal of Personalized Medicine. 2023; 13(6):923. https://doi.org/10.3390/jpm13060923

Hashimoto, Itaru, Kazuki Kano, Shizune Onuma, Hideaki Suematsu, Shinsuke Nagasawa, Kyohei Kanematsu, Kyoko Furusawa, Tomomi Hamaguchi, Mamoru Watanabe, Kei Hayashi, and et al. 2023. "Clinical Effect of the C-Reactive Protein to Serum Albumin Ratio in Patients with Metastatic Gastric or Gastroesophageal Junction Cancer Treated with Trifluridine/Tipiracil" Journal of Personalized Medicine 13, no. 6: 923. https://doi.org/10.3390/jpm13060923

Hashimoto, I., Kano, K., Onuma, S., Suematsu, H., Nagasawa, S., Kanematsu, K., Furusawa, K., Hamaguchi, T., Watanabe, M., Hayashi, K., Furuta, M., Inokuchi, Y., Machida, N., Aoyama, T., Yamada, T., Rino, Y., Ogata, T., & Oshima, T. (2023). Clinical Effect of the C-Reactive Protein to Serum Albumin Ratio in Patients with Metastatic Gastric or Gastroesophageal Junction Cancer Treated with Trifluridine/Tipiracil. Journal of Personalized Medicine, 13(6), 923. https://doi.org/10.3390/jpm13060923